COMPANY PROFILE

STH BIOTECH

Explore full profile

Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology

Évry-Courcouronnes, FranceFounded 2021Biotech & Life Sciences

Valuation <$5M Last recorded · 2024

Headcount <100 Current team size

Total funding $0–10M Disclosed equity funding

Unlock exact values

About STH BIOTECH

STH Biotech operates in the plant biotechnology sector, focusing on the exploration of minor cannabinoids and alkaloids to fuel pharmaceutical innovation. The company provides a unique production platform that addresses the accessibility challenges of plant-based compounds by significantly increasing yields through enhanced plant metabolism. This approach allows STH Biotech to deliver reliable and pure active pharmaceutical ingredients (APIs), empowering pharmaceutical companies in their pursuit of breakthrough medicines. The business model revolves around supplying these high-quality APIs to pharmaceutical firms, thereby generating revenue. STH Biotech's commitment to scalable, sustainable, and cost-efficient solutions positions it as a key player in the bioproduction market, aiming to drive transformative impacts on society and the environment.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Évry-Courcouronnes, France
Employees: 3
Open positions: None listed
Dealroom signal: 36.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Agritech, Sustainable Development Goals, Climate Tech, biotech medtech and e-health, Observatoire Deeptech, Greentech, observatoire greentech, observatoire industrial tech, DT and LS
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Jun 2024	$550K	$2.2M	Undisclosed	↗
SUPPORT PROGRAM✓Other financing	Feb 2022	$0	—	HEC Challenge+ · HEC Paris	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

STH BIOTECH website traffic

Latest recorded traffic for STH BIOTECH is 970 monthly website visits, up 94% over the last three months. STH BIOTECH's team declined 57.1% over the past year.

Latest monthly visits970 3-month web change+94% 1-year team growth-57.1%

Monthly website visitsJul 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBiomemoryProvides biodigital data storage for large companies and administrations	Paris, France	Operational	80	$24M	$72M
ABAbolis BiotechnologiesDesigns, Builds and Secure novel bio-processes for renewable chemical production with the help of engineered microbes	Évry-Courcouronnes, France	Operational
CBCore BiogenesisCore Biogenesis produces pharma-grade recombinant proteins with its plant-based bioproduction platform. Our first products are growth factors used for Cell Therapy manufacturing and Cultivated meat production	Strasbourg, France	Operational
SBSpore BiotechnologiesAI-powered real-time pathogen detection for factory floors.	Paris, France	Operational
PHphagosAI-powered bacteriophage therapies targeting antimicrobial resistance in animals	Suresnes, France	Operational
ABAlga BiologicsDeveloping therapeutic antibodies from microalgae using biotechnological processes for application in cancer treatment	Isneauville, France	Operational
MOMolsidWe fight AMR with Faster Diagnostics	Lyon, France	Operational
KOKolibriWe create the next-generation of bioreactors specifically designed to handle mammalian cells. Leveraging acoustic waves, our technology allows for increased yield while reducing production costs	Paris, France	Operational